Related Experiment Video

Updated: Jun 2, 2026

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos
07:24

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

The role of microRNA-150 as a tumor suppressor in malignant lymphoma

A Watanabe1, H Tagawa, J Yamashita

  • 1Department of Hematology, Nephrology and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan.

Leukemia
|April 20, 2011
PubMed

Insights

MicroRNA 150 (miR-150) acts as a tumor suppressor in natural killer (NK)/T-cell lymphoma. Its downregulation activates cancer-promoting pathways, leading to uncontrolled cell growth and immortalization.

Area of Science:

  • Molecular Biology
  • Oncology
  • RNA Biology

Background:

  • MicroRNAs (miRNAs) are small regulatory RNAs implicated in cancer development.
  • Aberrant expression of miR-21 and miR-155 activates the PI3K-AKT pathway in NK/T-cell lymphomas.
  • Previous research linked specific miRNAs to lymphoma pathogenesis.

Purpose of the Study:

  • To investigate the role of miR-150 in NK/T-cell lymphoma.
  • To determine the molecular mechanisms by which miR-150 influences lymphomagenesis.
  • To explore miR-150 as a potential tumor suppressor in this cancer type.

Main Methods:

  • Expression analysis of miR-150 in lymphoma cell lines and primary samples compared to normal NK cells.
  • Transduction of miR-150 into NK/T-cell lymphoma cells.
  • Assessment of apoptosis, cell proliferation, senescence, and telomerase activity.
  • Analysis of target gene expression (DKC1, AKT2) and downstream signaling pathways (AKT, Bim, p53).

Main Results:

  • miR-150 expression was significantly lower in NK/T-cell lymphoma compared to normal NK cells.
  • miR-150 transduction increased apoptosis, reduced proliferation, induced senescence, and shortened telomeres.
  • miR-150 directly downregulated DKC1 and AKT2, suppressed AKT phosphorylation, and increased tumor suppressors Bim and p53.
  • Downregulation of miR-150 correlated with continuous PI3K-AKT pathway activation.

Conclusions:

  • miR-150 functions as a tumor suppressor in NK/T-cell lymphoma.
  • Aberrant downregulation of miR-150 contributes to lymphomagenesis by activating the PI3K-AKT pathway and promoting cell immortalization.
  • These findings offer novel insights into the pathogenesis of malignant lymphoma and suggest miR-150 as a potential therapeutic target.

More Related Videos

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...